Hand-out
Press Releases
CytoSorbents Extends Expiration Date of Outstanding Series B Right Warrants
PRINCETON, N.J., April 4, 2025 /PRNewswire/ -- CytoSorbents Corporation (NASDAQ: CTSO), a leader in the treatment of life-threatening conditions in the intensive care unit and cardiac surgery using blood purification,
